Cargando…

Less may be more: nodal treatment in neck positive head neck cancer patients

Ongoing debates about the need and extent of planned neck dissection (PND), and required nodal radiation doses volumes lead to this evaluation. Aim was to assess nodal control after definitive intensity modulated radiation therapy (IMRT ± systemic therapy) followed by PND in our head neck cancer coh...

Descripción completa

Detalles Bibliográficos
Autores principales: Studer, Gabriela, Huber, Gerhard F., Holz, Edna, Glanzmann, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858567/
https://www.ncbi.nlm.nih.gov/pubmed/25920604
http://dx.doi.org/10.1007/s00405-015-3634-5
_version_ 1782430824485879808
author Studer, Gabriela
Huber, Gerhard F.
Holz, Edna
Glanzmann, Christoph
author_facet Studer, Gabriela
Huber, Gerhard F.
Holz, Edna
Glanzmann, Christoph
author_sort Studer, Gabriela
collection PubMed
description Ongoing debates about the need and extent of planned neck dissection (PND), and required nodal radiation doses volumes lead to this evaluation. Aim was to assess nodal control after definitive intensity modulated radiation therapy (IMRT ± systemic therapy) followed by PND in our head neck cancer cohort with advanced nodal disease. Between 01/2005 and 12/2013, 99 squamous cell cancer HNC patients with pre-therapeutic nodal metastasis ≥3 cm were treated with definitive IMRT followed by PND. In addition, outcome in 103 patients with nodal relapse after IMRT and observation only (no-PND cohort) were analyzed. Prior to PND, PET–CT, fine needle aspirations, ultrasound and palpation were assessed regarding its predictive value. Patterns of nodal relapse were assessed in patients with isolated neck failure after definitive IMRT alone. 70/99 (70 %) PND specimens showed histopathological complete response (hCR), which translated into statistically significantly superior survival compared with partial response (hPR) with 4-year overall survival, disease specific survival and nodal control rates of 90/83/96 vs 67/60/78 % (p = 0.002/0.001/0.003). 1/99 patient developed isolated subsequent nodal disease. 64/2147 removed nodes contained viable tumor (3 %). Predictive information of the performed diagnostic investigations was not reliable. 17/70 hCR patients showed true negative findings in available three to four investigations (0/29 hPR). 27/103 no-PND patients developed isolated neck disease (26 %) with successful salvage in 21/24 [88 %, or 21/27 (78 %)]. Nearly all failures occurred in the prior nodal gross tumor volume area. A more restrictive approach regarding PND and/or nodal IMRT dose-volumes may be justified.
format Online
Article
Text
id pubmed-4858567
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-48585672016-05-21 Less may be more: nodal treatment in neck positive head neck cancer patients Studer, Gabriela Huber, Gerhard F. Holz, Edna Glanzmann, Christoph Eur Arch Otorhinolaryngol Head and Neck Ongoing debates about the need and extent of planned neck dissection (PND), and required nodal radiation doses volumes lead to this evaluation. Aim was to assess nodal control after definitive intensity modulated radiation therapy (IMRT ± systemic therapy) followed by PND in our head neck cancer cohort with advanced nodal disease. Between 01/2005 and 12/2013, 99 squamous cell cancer HNC patients with pre-therapeutic nodal metastasis ≥3 cm were treated with definitive IMRT followed by PND. In addition, outcome in 103 patients with nodal relapse after IMRT and observation only (no-PND cohort) were analyzed. Prior to PND, PET–CT, fine needle aspirations, ultrasound and palpation were assessed regarding its predictive value. Patterns of nodal relapse were assessed in patients with isolated neck failure after definitive IMRT alone. 70/99 (70 %) PND specimens showed histopathological complete response (hCR), which translated into statistically significantly superior survival compared with partial response (hPR) with 4-year overall survival, disease specific survival and nodal control rates of 90/83/96 vs 67/60/78 % (p = 0.002/0.001/0.003). 1/99 patient developed isolated subsequent nodal disease. 64/2147 removed nodes contained viable tumor (3 %). Predictive information of the performed diagnostic investigations was not reliable. 17/70 hCR patients showed true negative findings in available three to four investigations (0/29 hPR). 27/103 no-PND patients developed isolated neck disease (26 %) with successful salvage in 21/24 [88 %, or 21/27 (78 %)]. Nearly all failures occurred in the prior nodal gross tumor volume area. A more restrictive approach regarding PND and/or nodal IMRT dose-volumes may be justified. Springer Berlin Heidelberg 2015-04-29 2016 /pmc/articles/PMC4858567/ /pubmed/25920604 http://dx.doi.org/10.1007/s00405-015-3634-5 Text en © The Author(s) 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Head and Neck
Studer, Gabriela
Huber, Gerhard F.
Holz, Edna
Glanzmann, Christoph
Less may be more: nodal treatment in neck positive head neck cancer patients
title Less may be more: nodal treatment in neck positive head neck cancer patients
title_full Less may be more: nodal treatment in neck positive head neck cancer patients
title_fullStr Less may be more: nodal treatment in neck positive head neck cancer patients
title_full_unstemmed Less may be more: nodal treatment in neck positive head neck cancer patients
title_short Less may be more: nodal treatment in neck positive head neck cancer patients
title_sort less may be more: nodal treatment in neck positive head neck cancer patients
topic Head and Neck
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858567/
https://www.ncbi.nlm.nih.gov/pubmed/25920604
http://dx.doi.org/10.1007/s00405-015-3634-5
work_keys_str_mv AT studergabriela lessmaybemorenodaltreatmentinneckpositiveheadneckcancerpatients
AT hubergerhardf lessmaybemorenodaltreatmentinneckpositiveheadneckcancerpatients
AT holzedna lessmaybemorenodaltreatmentinneckpositiveheadneckcancerpatients
AT glanzmannchristoph lessmaybemorenodaltreatmentinneckpositiveheadneckcancerpatients